1-(2-Hydroxy-4-methylcyclohexyl)ethan-1-one
Common Name: |
1-(2-Hydroxy-4-methylcyclohexyl)ethan-1-one |
IUPAC Name: |
1-(2-hydroxy-4-methylcyclohexyl)ethanone |
Molecular Formula: |
C15H22O |
SMILES: |
CC1CCC(C(C1)O)C(=O)C |
Inchi: |
1S/C9H16O2/c1-6-3-4-8(7(2)10)9(11)5-6/h6,8-9,11H,3-5H2,1-2H3 |
Inchi Key: |
VISJALGWOBQNEJ-UHFFFAOYSA-N |
Cas No: |
917750-72-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
218.33 |
Mass (g/mol) |
156.115 |
Molar Refractivity |
68.98 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
250.43 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
1.372 |
iLOGP |
3.16 |
XLOGP3 |
4.42 |
WLOGP |
4.19 |
MLOGP |
3.46 |
ESOL Log S |
-3.71 |
ESOL Solubility (mg/ml) |
0.042 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.50 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.61 |
Silicos-IT Solubility (mg/ml) |
0.05 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.49 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.623 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.027 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |